Position in CGEM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$10,399,364
+$4,015,411 QoQ
Shares Held
571,080
+27.1% QoQ
Ownership
0.887%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#24
of 183 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in CGEM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. CGEM ranks #114 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in CGEM
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,399,364 | 571,080 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $6,383,953 | 449,258 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $4,363,921 | 421,635 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $2,652,291 | 447,267 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $3,412,615 | 453,203 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $3,663,037 | 483,889 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $6,101,057 | 500,908 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $7,882,612 | 470,885 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $5,177,098 | 296,852 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $4,497,689 | 263,949 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,719,933 | 266,922 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,306,092 | 254,817 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,545,147 | 236,538 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,542,951 | 248,578 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,050,373 | 289,135 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,512,461 | 273,983 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,452,130 | 269,277 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,501,731 | 238,943 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,570,239 | 231,383 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $5,168,597 | 229,003 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,408,629 | 132,374 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,885,470 | 141,240 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||